HealthInvest Partners’s Centene CNC Stock Holding History

HealthInvest Partners’s Portfolio CNC Stock Details CNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-62,000	Closed	-$4.6M	–	47
2023 Q4	$4.6M	Buy	+62,000	New	+$4.47M	3.6%	10

Other funds holding CNC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

PCM

Politan Capital Management New York $985M AUM 3.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HealthInvest Partners's CNC Position: Q1 2024 in Review

HealthInvest Partners sold out of Centene (CNC) in Q1 2024, closing a stake of 62,000 shares — an estimated $4.6M sold.

HealthInvest Partners first reported a position in CNC in Q4 2023 and held it in 1 quarter. The position peaked at $4.6M in Q4 2023. 931 funds tracked by Wall St. Rank hold CNC as of Q1 2024.

HealthInvest Partners reported no remaining Centene position as of Q1 2024 after selling out during the quarter.
HealthInvest Partners sold 62,000 Centene shares in Q1 2024, an estimated $4.6M.
HealthInvest Partners first reported a position in Centene in Q4 2023 and held it in 1 quarter.
HealthInvest Partners's Centene position peaked at $4.6M in Q4 2023.
931 funds tracked by Wall St. Rank held Centene as of Q1 2024.

Based on HealthInvest Partners's 13F filing for Q1 2024, filed 25 Apr 2024.